You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice

About Guidelines Email Guidelines Team

What's New in Guidelines & Advice

All documents recently added to the Guidelines & Advice area within the last 6 months are available here, as well as any updated documents.

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2020

Document Status: Current

ID: PET 2020-1

Version: N/A

New

Nov 2020

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Document Status: Current

Oct 2020

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Document Status: Current

ID: GL 4-18

Version: N/A

Sep 2020

Risk Reduction Strategies for BRCA1/2 Hereditary Ovarian Cancer Syndromes

Document Status: Current

ID: GL #4-4v2

Version: 2

Sep 2020

Summary of Recommendations for Primary Care Management after Stem Cell Transplant

Document Status: Current

Version: 1

Jul 2020

Screening for Secondary Solid Malignancies after Stem Cell Transplant

Document Status: Current

Version: 1

Jul 2020

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Document Status: Current

ID: ES 23-2

Version: N/A

Jun 2020

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2019

Document Status: Current

ID: PET 2019-2

Version: N/A

Jun 2020

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Document Status: Current

ID: RR SCT-9

Version: N/A

Jun 2020